Apex Scientific

21+ access.
Research use only.

Before entering, confirm that you meet the age requirement and understand the research-use limitations that apply to every Apex product.

Leave site

Your acknowledgement is remembered on this device for 30 days.

Research use only Clear product information Free shipping on orders over $200 20% launch offer · Use code APEX101

Compound guide

SS-31

A pathway-focused guide to molecular mechanisms, published evidence, and the limits of interpretation.

Overview

A Summary:SS-31

SS-31, also called elamipretide, is a short mitochondria-targeting tetrapeptide studied for its interaction with cardiolipin in the inner mitochondrial membrane.

Its cardiolipin interactions are investigated for effects on membrane organization, respiratory-chain efficiency, ATP production, and oxidative-stress responses.

SS-31 has substantial preclinical literature and has entered clinical trials in selected disorders, but findings are indication-specific and do not establish a general consumer benefit.

Research model

Cellular & MolecularHow SS-31 Is Studied

These receptors, enzymes, and signaling networks define the primary laboratory questions associated with this research material.

01Mitochondrial targeting

Cardiolipin membrane binding

At the cellular or molecular level

SS-31 associates with cardiolipin, a negatively charged phospholipid concentrated in the inner mitochondrial membrane. Cardiolipin helps organize membrane shape and respiratory proteins.

02Respiratory efficiency

Electron-transport organization

At the cellular or molecular level

Preclinical work suggests cardiolipin interactions can support cristae structure and the arrangement of electron-transport proteins, including the relationship between cardiolipin and cytochrome c.

03Oxidative-stress response

Redox balance

At the cellular or molecular level

By influencing membrane and electron-transport behavior, SS-31 is proposed to reduce excessive reactive-oxygen-species formation and downstream oxidative damage in stressed cells.

Research interpretation

How to read the pathway.

01

Mitochondrial targeting

SS-31 associates with cardiolipin, a negatively charged phospholipid concentrated in the inner mitochondrial membrane.

02

Respiratory efficiency

Preclinical work suggests cardiolipin interactions can support cristae structure and the arrangement of electron-transport proteins, including the relationship between cardiolipin and cytochrome c.

03

Oxidative-stress response

By influencing membrane and electron-transport behavior, SS-31 is proposed to reduce excessive reactive-oxygen-species formation and downstream oxidative damage in stressed cells.

Evidence boundary

SS-31 has substantial preclinical literature and has entered clinical trials in selected disorders, but findings are indication-specific and do not establish a general consumer benefit.

Read the evidence

Sources BehindThis Guide

Elamipretide mechanism review (opens in a new tab)MMPOWER-3 randomized clinical trial (opens in a new tab)Elamipretide (SS-31) identity record (opens in a new tab)

One important note

Educational Notice

SS-31 has been tested in human mitochondrial-disease trials. Early studies reported selected signals, while the larger MMPOWER-3 trial did not improve its primary walking-distance or fatigue endpoints.

This guide summarizes molecular mechanisms, published evidence, and evidence limits in everyday language. It is educational information, not medical advice or instructions for personal use. Products offered on this site are intended exclusively for laboratory research and are not for human or veterinary use.